- Home
- ZOOZ vs IBIO Comparison
ZOOZ vs IBIO Comparison
Compare ZOOZ & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZOOZ
- IBIO
- Stock Information
- Founded
- ZOOZ 2013
- IBIO 2008
- Country
- ZOOZ Israel
- IBIO United States
- Employees
- ZOOZ N/A
- IBIO N/A
- Industry
- ZOOZ
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ZOOZ
- IBIO Health Care
- Exchange
- ZOOZ NYSE
- IBIO Nasdaq
- Market Cap
- ZOOZ 13.4M
- IBIO 15.9M
- IPO Year
- ZOOZ N/A
- IBIO N/A
- Fundamental
- Price
- ZOOZ $0.98
- IBIO $0.71
- Analyst Decision
- ZOOZ Strong Buy
- IBIO Strong Buy
- Analyst Count
- ZOOZ 2
- IBIO 3
- Target Price
- ZOOZ $5.00
- IBIO $4.87
- AVG Volume (30 Days)
- ZOOZ 33.5K
- IBIO 5.3M
- Earning Date
- ZOOZ 08-11-2025
- IBIO 05-02-2025
- Dividend Yield
- ZOOZ N/A
- IBIO N/A
- EPS Growth
- ZOOZ N/A
- IBIO N/A
- EPS
- ZOOZ N/A
- IBIO N/A
- Revenue
- ZOOZ $1,041,000.00
- IBIO $375,000.00
- Revenue This Year
- ZOOZ $32.28
- IBIO $36.00
- Revenue Next Year
- ZOOZ $192.59
- IBIO N/A
- P/E Ratio
- ZOOZ N/A
- IBIO N/A
- Revenue Growth
- ZOOZ 36.26
- IBIO 650.00
- 52 Week Low
- ZOOZ $0.73
- IBIO $0.64
- 52 Week High
- ZOOZ $3.07
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- ZOOZ N/A
- IBIO 37.70
- Support Level
- ZOOZ N/A
- IBIO $0.68
- Resistance Level
- ZOOZ N/A
- IBIO $1.04
- Average True Range (ATR)
- ZOOZ 0.00
- IBIO 0.12
- MACD
- ZOOZ 0.00
- IBIO -0.00
- Stochastic Oscillator
- ZOOZ 0.00
- IBIO 7.89
About ZOOZ ZOOZ POWER LTD
Zooz Power Ltd is a provider of Flywheel-based Power Boosting solutions enabling widespread deployment of ultra-fast charging infrastructure for electric vehicles (EV) while overcoming existing grid limitations. ZOOZ pioneers its flywheel-based power boosting technology, enabling efficient utilization and power management of a power-limited grid at an EV charging site. Its Flywheel technology allows high-performance, reliable, and cost-effective ultra-fast charging infrastructure. ZOOZ Power's sustainable, power-boosting solutions are built with longevity and the environment in mind, helping its customers and partners accelerate the deployment of fast-charging infrastructure, thus facilitating improved utilization rates, efficiency and greater flexibility.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.